Abstract
We developed a camel-inspired medication to treat sickle cell disease, a sulfated non-anticoagulant low-molecular weight heparin (SNACH). Camel-derived SNACH has been shown pre-clinically to me more
efficacious than the currently available therapies for sickle cell disease and sickle cell crisis due in part to its multi-model mechanisms of action. While current therapies attempt to treat sickle cell disease via one mechanism, SNACH has a number of independent mechanisms of action that serve to rapidly resolve or prevent sickle cell crises by acting as an anti-sickling, anti-thrombotic, anti-selectin and anti-adhesive. Nanoformulated SNACH with camel milk lactoferrin demonstrated high oral bioavailability in Sickle cell, cancer, inflammatory, and infectious diseases. Dr. Mousa has also applied his expertise in the area of Nanoformulation to use natural products, such as mushroom and shellfish-derived polycationic chitosan or camel milk, lactoferrin to Nanoformulate prophetically recomm
efficacious than the currently available therapies for sickle cell disease and sickle cell crisis due in part to its multi-model mechanisms of action. While current therapies attempt to treat sickle cell disease via one mechanism, SNACH has a number of independent mechanisms of action that serve to rapidly resolve or prevent sickle cell crises by acting as an anti-sickling, anti-thrombotic, anti-selectin and anti-adhesive. Nanoformulated SNACH with camel milk lactoferrin demonstrated high oral bioavailability in Sickle cell, cancer, inflammatory, and infectious diseases. Dr. Mousa has also applied his expertise in the area of Nanoformulation to use natural products, such as mushroom and shellfish-derived polycationic chitosan or camel milk, lactoferrin to Nanoformulate prophetically recomm
Keywords
Prophetic Medicine
